- Knowledge Base
- Latest News
- July 2019
-
Latest News
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- February 2019
- January 2019
- November 2018
- June 2018
- January 2018
- November 2017
-
Product Help and Guides
- Coronavirus Help Centre
- Vision 3 Release Guides
- Consultation Manager
- Vision +
- SIS Vision+ Release Guides
- Registration
- Patient Services
- Vision 3 Appointments
- Daybook
- Search and Reports
- Clinical Audit
- Mail Manager
- Management Tools
- Registration Links
- GP Communicator
- Utilities
- Outcomes Manager
- Vision Anywhere
- Vision Anywhere - Release Guides
- Appointments
- Appointments Setup
- Appointments Reporting
- Tasks
- Shared Care
- Community
- General Hints and Tips
- England Only
- Scotland Only
- Wales Only
- Northern Ireland Only
- Medication and Clinical Term Dictionaries
- Partner Solutions
- Seasonal Influenza 2020-21 Help Centre
- Patient Groups
- Flash Cards
-
Webinars and Events
-
Training and Support
-
Downloads
-
vStore and Partners
Clinical Safety Issue - Vision+ Anticoagulation Manager
An issue has been discovered with the use of the Anticoagulation Manager module available in the Vision+ product that may be used for managing the appropriate treatment of patients requiring anticoagulation therapy.
Background
An issue has been discovered with the use of the Anticoagulation Manager module available in the Vision+ product that may be used for managing the appropriate treatment of patients requiring anticoagulation therapy. The issue identified is in relation to some dosing instructions possibly being missing in a printout generated from Vision+ Anticoagulation Manager. Where such a printout is given to a patient, there is a risk of under or overdosing with associated consequences.
The issue is experienced as a result of amending the font size for the on-screen display using the "Make text and other items larger or smaller" control, resulting in an adverse effect on the printout.
The following example screen shots using dummy test patient data illustrate where the font size has been increased for a patient with a 7-day Warfarin dosage regimen.
Warfarin Dose
Dosing Instructions – Enlarged On-Screen View
Dosing Instructions – Printout
In the enlarged on-screen view, only the dosing instructions for Thu, Fri, Sat, Sun and Mon are displayed and the dosage information for Tue and Wed is missing.
In the printout, only the dosing instructions for Thu, Fri, Sat, Sun, Mon and Tue are displayed and the dosage information Wed is missing.
A fix will be deployed that will fully resolve this issue in Vision+ Anticoagulation Manager.
Actions
In the meantime, in mitigation of the associated risk, users of the Vision+ Anticoagulation Manager module are advised not to alter the font size for the on-screen display as this may also affect the printout that may be given to a patient.